Nutrition interventions play a central role in the treatment and management of inflammatory bowel disease in children. Malnutrition is a common presenting symptom in both pediatric ulcerative colitis and Crohn’s disease and is associated with increased morbidity. Providing macronutrients can improve growth; likewise, identifying and correcting micronutrient deficiencies can improve comorbid conditions like osteopenia and anemia. Although many patients manipulate their diets to help treat their inflammatory bowel disease, only parenteral nutrition with bowel rest and exclusive enteral nutrition therapy have been shown effective for the treatment of inflammatory bowel disease.
OlivaMMLakeAM. Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition. 1996;12:151-158.
2.
MotilKJGrandRJDavis-KraftLFerlicLLSmithEO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993;105:681-691.
3.
RosenthalSRSnyderJDHendricksKMWalkerWA. Growth failure and inflammatory bowel disease: approach to treatment of a complicated adolescent problem. Pediatrics. 1983;72:481-490.
4.
KanofMELakeAMBaylessTM. Decreased height velocity in children and adolescents before the diagnosis of Crohn’s disease. Gastroenterology. 1988;95:1523-1527.
CastileRGTelanderRLCooneyDR. Crohn’s disease in children: assessment of the progression of disease, growth, and prognosis. J Pediatr Surg. 1980;15:462-469.
7.
SentongoTASemeaoEJPiccoliDAStallingsVAZemelBS. Growth, body composition, and nutritional status in children and adolescents with Crohn’s disease. J Pediatr Gastroenterol Nutr. 2000;31:33-40.
8.
HildebrandHKarlbergJKristianssonB. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994;18:165-173.
9.
HartmanCEliakimRShamirR. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009;15:2570-2578.
10.
KleinmanREBaldassanoRNCaplanA. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology And Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:15-27.
11.
MishkinS. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997;65:564-567.
12.
GokhaleRFavusMJKarrisonTSuttonMMRichBKirschnerBS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902-911.
13.
LopesLHSdepanianVLSzejnfeldVLde MoraisMBFagundes-NetoU. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease. Dig Dis Sci. 2008;53:2746-2753.
14.
SentongoTASemaeoEJStettlerNPiccoliDAStallingsVAZemelBS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002;76:1077-1081.
15.
PappaHMGrandRJGordonCM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006;12:1162-1174.
16.
IssenmanRMAtkinsonSARadojaCFraherL. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr. 1993;17:401-406.
17.
BousvarosAZurakowskiDDugganC. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998;26:129-135.
18.
SchoonEJMullerMCVermeerCSchurgersLJBrummerRJStockbruggerRW. Low serum and bone vitamin K status in patients with longstanding Crohn’s disease: another pathogenetic factor of osteoporosis in Crohn’s disease?Gut. 2001;48:473-477.
19.
KuwabaraATanakaKTsugawaN. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int. 2009;20:935-942.
Revel-VilkSTamaryHBroideE. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr. 2000;159:585-589.
22.
ErichsenKUlvikRJNysaeterG. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol. 2005;40:1058-1065.
23.
de SilvaADTsironiEFeakinsRMRamptonDS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther. 2005;22:1097-1105.
24.
SchroderOMickischOSeidlerU. Intravenous iron sucrose vs oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease—a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100:2503-2509.
25.
HarveyRSReffittDMDoigLA. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther. 1998;12:845-848.
26.
NakanoETaylorCJChadaLMcGawJPowersHJ. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2003;37:586-590.
27.
HeymanMBGarnettEAShaikhNJoseFAHarmatzPWinterHSBaldassanoRNCohenSAGoldBDKirschnerBSFerryGDStegeEHollandN. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease. Am J Clin Nutr. 2009;89:545-50.
28.
PhelipJMDucrosVFaucheronJLFlourieBRoblinX. Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:242-248.
29.
BjerregaardLTNederbyNJFredholmLBrandslundIMunkholmPHeyH. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:62-67.
30.
BelliDCSeidmanEBouthillierL. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology. 1988;94:603-610.
31.
PolkDBHattnerJAKernerJAJr. Improved growth and disease activity after intermittent administration of a defined formula diet in children with Crohn’s disease. JPEN J Parenter Enteral Nutr. 1992;16:499-504.
32.
KleinmanREBalistreriWFHeymanMB. Nutritional support for pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1989;8:8-12.
33.
GerasimidisKMcGroganPHassanKEdwardsCA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27:155-165.
34.
SakamotoNKonoSWakaiK. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11:154-163.
35.
RitchieJKWadsworthJLennard-JonesJERogersE. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn’s disease. Br Med J (Clin Res Ed). 1987;295:517-520.
36.
LevensteinSPranteraCLuziCD’UbaldiA. Low residue or normal diet in Crohn’s disease: a prospective controlled study in Italian patients. Gut. 1985;26:989-993.
37.
BrandesJWLorenz-MeyerH. Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Z Gastroenterol. 1981;19:1-12.
38.
MishkinBYalovskyMMishkinS. Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997;92:1148-1153.
39.
Lorenz-MeyerHBauerPNicolayC. ω-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn’s disease: a randomized controlled multicenter trial. Study Group Members (German Crohn’s Disease Study Group). Scand J Gastroenterol. 1996;31:778-785.
40.
BelluzziABrignolaCCampieriMPeraABoschiSMiglioliM. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med. 1996;334:1557-1560.
41.
AslanATriadafilopoulosG. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol. 1992;87:432-437.
42.
HawthorneABDaneshmendTKHawkeyCJ. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut. 1992;33:922-928.
43.
StensonWFCortDRodgersJ. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992;116:609-614.
44.
GreenfieldSMGreenATTeareJP. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993;7:159-166.
45.
MullenJLHargroveWCDudrickSJFittsWTJrRosatoEF. Ten years experience with intravenous hyperalimentation and inflammatory bowel disease. Ann Surg. 1978;187:523-529.
46.
ScolapioJS. The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol. 1999;29:223-224.
47.
StrobelCTByrneWJAmentME. Home parenteral nutrition in children with Crohn’s disease: an effective management alternative. Gastroenterology. 1979;77:272-279.
48.
DayASWhittenKELembergDA. Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006;21:1609-1614.
49.
HartmanCBerkowitzDWeissB. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn’s disease. Isr Med Assoc J. 2008;10:503-507.
50.
HeuschkelRBMenacheCCMegerianJTBairdAE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8-15.
51.
JohnsonTMacdonaldSHillSMThomasAMurphyMS. Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006;55:356-361.
52.
DziechciarzPHorvathAShamirRSzajewskaH. Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther. 2007;26:795-806.
53.
AfzalNADaviesSPaintinM. Colonic Crohn’s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci. 2005;50:1471-1475.
54.
KnightCEl-MataryWSprayCSandhuBK. Long-term outcome of nutritional therapy in paediatric Crohn’s disease. Clin Nutr. 2005;24:775-779.
55.
LudvigssonJFKrantzMBodinLStenhammarLLindquistB. Elemental vs polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized controlled trial. Acta Paediatr. 2004;93:327-335.
56.
FellJM. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr. 2005;29(4 Suppl):S126-8; discussion S9-S33,S84-S88.
57.
AkobengAKMillerVStantonJElbadriAMThomasAG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr. 2000;30:78-84.
